Dana-Farber Cancer Institute
The Visiting Scientist will collaborate with postdoctoral fellows in the Barbie lab at Dana-Farber Cancer Institute to investigate T-cell-based therapies for KRAS inhibitor drug-tolerant persister cells. The role focuses on human in vitro cell line models and contributes to the institute's mission of advancing cancer research and patient care. This position offers an opportunity to work within an inclusive and innovative research environment dedicated to conquering cancer and related diseases.
Headquarters
Boston, Massachusetts, United States
Company Size
1001-5000 employees
Founded
1947
Dana‑Farber Cancer Institute, based in Boston, MA, is a world‑leading cancer center specializing in adult and pediatric cancer treatment and research. Its physician‑scientists deliver multidisciplinary patient care and develop many of the most advanced therapies, including targeted treatments and clinical trials. Dana‑Farber combines cutting‑edge laboratory research with translational programs, prevention and survivorship services, and education to improve outcomes. Patients and clinicians turn to Dana‑Farber for its expertise, comprehensive care teams, and strong research pipeline.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Dana-Farber Cancer Institute.
DNA company aids Horry Co. in solving cold cases
Nov 26, 2025